An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

2,275

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions.

Trial Locations (41)

12038

Novo Nordisk Investigational Site, Savigliano (CN)

14000

Novo Nordisk Investigational Site, Prague

20089

Novo Nordisk Investigational Site, Rozzano (MI)

20162

Novo Nordisk Investigational Site, Milan

25001

Novo Nordisk Investigational Site, Brandýs nad Labem

26200

Novo Nordisk Investigational Site, Montélimar

28000

Novo Nordisk Investigational Site, Chartres

29471

Novo Nordisk Investigational Site, Benátky nad Jizerou

30100

Novo Nordisk Investigational Site, Pilsen

37024

Novo Nordisk Investigational Site, Negrar (VR)

43004

Novo Nordisk Investigational Site, Chomutov

44123

Novo Nordisk Investigational Site, Ferrara

48121

Novo Nordisk Investigational Site, Ravenna

50012

Novo Nordisk Investigational Site, Bagno a Ripoli

50134

Novo Nordisk Investigational Site, Florence

50341

Novo Nordisk Investigational Site, Hradec Králové

61032

Novo Nordisk Investigational Site, Fano

63120

Novo Nordisk Investigational Site, Courpière

67000

Novo Nordisk Investigational Site, Strasbourg

68001

Novo Nordisk Investigational Site, Boskovice

69002

Novo Nordisk Investigational Site, Břeclav

69007

Novo Nordisk Investigational Site, Lyon

69170

Novo Nordisk Investigational Site, Tarare

69200

Novo Nordisk Investigational Site, Vénissieux

69580

Novo Nordisk Investigational Site, Sathonay-Camp

70200

Novo Nordisk Investigational Site, Ostrava

71200

Novo Nordisk Investigational Site, Le Creusot

71800

Novo Nordisk Investigational Site, Ostrava

72100

Novo Nordisk Investigational Site, Brindisi

73514

Novo Nordisk Investigational Site, Orlová

76680

Novo Nordisk Investigational Site, Saint-Saëns

76701

Novo Nordisk Investigational Site, Kroměříž

77900

Novo Nordisk Investigational Site, Olomouc

80121

Novo Nordisk Investigational Site, Napoli

83031

Novo Nordisk Investigational Site, Ariano Irpino

88100

Novo Nordisk Investigational Site, Catanzaro

90047

Novo Nordisk Investigational Site, Partinico (PA)

98128

Novo Nordisk Investigational Site, Messina

00041

Novo Nordisk Investigational Site, Albano Laziale

05018

Novo Nordisk Investigational Site, Orvieto

00161

Novo Nordisk Investigational Site, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY